Cargando…
Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study
PURPOSE: Not all patients with stage III non-small cell lung cancer (NSCLC) are suitable for concurrent chemoradiation therapy (CRT). Local failure rate is high for sequential concurrent CRT. As such, there is a rationale for treatment intensification. METHODS AND MATERIALS: Isotoxic intensity modul...
Autores principales: | Haslett, Kate, Bayman, Neil, Franks, Kevin, Groom, Nicki, Harden, Susan V., Harris, Catherine, Hanna, Gerard, Harrow, Stephen, Hatton, Matthew, McCloskey, Paula, McDonald, Fiona, Ryder, W. David, Faivre-Finn, Corinne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier, Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955281/ https://www.ncbi.nlm.nih.gov/pubmed/33232772 http://dx.doi.org/10.1016/j.ijrobp.2020.11.040 |
Ejemplares similares
-
Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study
por: Haslett, Kate, et al.
Publicado: (2016) -
Association between radiotherapy protocol variations and outcome in the CONVERT trial
por: Mir, Romaana, et al.
Publicado: (2022) -
Treating locally advanced lung cancer with a 1.5 T MR-Linac – Effects of the magnetic field and irradiation geometry on conventionally fractionated and isotoxic dose-escalated radiotherapy
por: Bainbridge, Hannah E., et al.
Publicado: (2017) -
Correction: Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study
Publicado: (2016) -
Association of Chemoradiotherapy With Outcomes Among Patients With Stage I to II vs Stage III Small Cell Lung Cancer: Secondary Analysis of a Randomized Clinical Trial
por: Salem, Ahmed, et al.
Publicado: (2018)